1. Home
  2. CATO vs SPRO Comparison

CATO vs SPRO Comparison

Compare CATO & SPRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cato Corporation (The)

CATO

Cato Corporation (The)

N/A

Current Price

$2.34

Market Cap

67.9M

ML Signal

N/A

Logo Spero Therapeutics Inc.

SPRO

Spero Therapeutics Inc.

SELL

Current Price

$1.14

Market Cap

67.0M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CATO
SPRO
Founded
1946
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Clothing/Shoe/Accessory Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
67.9M
67.0M
IPO Year
1994
2017

Fundamental Metrics

Financial Performance
Metric
CATO
SPRO
Price
$2.34
$1.14
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $5.00
AVG Volume (30 Days)
51.6K
★ 839.8K
Earning Date
11-19-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
68.04
★ 111.81
EPS
★ 0.53
N/A
Revenue
★ $653,812,000.00
$66,802,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$4.45
★ N/A
Revenue Growth
0.62
★ 39.24
52 Week Low
$2.29
$1.08
52 Week High
$4.59
$3.08

Technical Indicators

Market Signals
Indicator
CATO
SPRO
Relative Strength Index (RSI) 38.34 44.31
Support Level $2.30 $1.10
Resistance Level $2.46 $1.28
Average True Range (ATR) 0.05 0.06
MACD 0.02 -0.00
Stochastic Oscillator 35.34 15.00

Price Performance

Historical Comparison
CATO
SPRO

About CATO Cato Corporation (The)

The Cato Corp seeks to offer quality fashion apparel and accessories at low prices every day, in junior/missy and plus sizes. The Cato concept's stores and e-commerce website feature a broad assortment of apparel and accessories, including dressy, career, and casual sportswear, dresses, coats, shoes, lingerie, costume jewelry, and handbags. Management believes the Company's success is dependent upon its ability to differentiate its stores from department stores, mass merchandise discount stores, and competing specialty stores. The key elements of the Company's business are: Merchandise Assortment, Value Pricing, Strip Shopping Center Location, Customer Service, Credit and Layaway Programs.

About SPRO Spero Therapeutics Inc.

Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing, and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. It is also focused on SPR206, a next-generation polymyxin investigational product candidate being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.

Share on Social Networks: